Literature DB >> 514458

Ephedrine: a postsynaptic depressant drug at the mammalian neuromuscular junction.

P Shinnick-Gallagher, J P Gallagher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 514458     DOI： 10.1016/0028-3908(79)90018-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  2 in total

Review 1.  Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Authors:  Charlotte Vrinten; Angeli M van der Zwaag; Stephanie S Weinreich; Rob J P M Scholten; Jan J G M Verschuuren
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

2.  Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.

Authors:  Charlotte Vrinten; Alexander F Lipka; Erik W van Zwet; Kirsten J M Schimmel; Martina C Cornel; Marja R Kuijpers; Yechiel A Hekster; Stephanie S Weinreich; Jan J G M Verschuuren
Journal:  BMJ Open       Date:  2015-07-16       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.